Back

Estrogen-induced phenotype in hiPSC-derived cardiomyocytes of a woman affected by both Long QT Syndrome Type 2 and Polycystic Ovary Syndrome

25 August 2023 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of ventricular arrhythmias Arrhythmias ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Massimiliano Gnecchi

University of Pavia, Pavia (Italy)

7 More presentations in this session

Presentation thumbnail
Roles of aldosterone on ventricular arrhythmias, and associated gap junction and ion channel remodeling in hypertrophic heart
Associate Professor M. Kobara (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
The dominant-negative effect of Loss of function Nav 1.5 variants is not a critical determinant of phenotype severity
Doctor K. Kato (Otsu, JP)
Abstract Slides Video
Presentation thumbnail
Cardiosphere derived cell secretome therapy after experimental myocardial infarction: effects of intracoronary administration on ventricular tachycardia inducibility and cardiac function
Doctor V. Blanco Blazquez (Caceres, ES)
Abstract Slides Video
Presentation thumbnail
Cardiac sympathetic hyperinnervation after myocardial infarction: a systematic review and qualitative analysis
Ms L. Van Roon (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Chd4 and Zbtb7b cooperate to inhibit Cardiac Arrhythmia by repressing Cornifin-A expression
Assistant Professor P. Gomez del Arco (Majadahonda, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of ventricular arrhythmias

The Event

Event poster

ESC Congress 2023

25 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Menstruation-triggered malignant arrhythmias in a young woman with LQTS type 2 and anomalous RCA
30 March 2025
thumbnail
Congress Presentation
Sex differences in atrial electrical properties
4 April 2022
thumbnail
Congress Presentation
The role of sex hormones in Takotsubo syndrome: a preclinical investigation
31 August 2025
thumbnail
Congress Presentation
Efficacy and safety of HERG channel agonists for treatment of Long QT Syndrome type 8
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources